Literature DB >> 15181535

An ENU-induced mutation in AP-2alpha leads to middle ear and ocular defects in Doarad mice.

Nadav Ahituv1, Alexandra Erven, Helmut Fuchs, Keren Guy, Ruth Ashery-Padan, Trevor Williams, Martin Hrabe de Angelis, Karen B Avraham, Karen P Steel.   

Abstract

One of the advantages of N-ethyl- N-nitrosourea (ENU)-induced mutagenesis is that, after randomly causing point mutations, a variety of alleles can be generated in genes leading to diverse phenotypes. For example, transcription factor AP-2alpha ( Tcfap2a) null homozygote mice show a large spectrum of developmental defects, among them missing middle ear bones and tympanic ring. This is the usual occurrence, where mutations causing middle ear anomalies usually coincide with other abnormalities. Using ENU-induced mutagenesis, we discovered a new dominant Tcfap2a mutant named Doarad ( Dor) that has a missense mutation in the PY motif of its transactivation domain, leading to a misshapen malleus, incus, and stapes without any other observable phenotype. Dor homozygous mice die perinatally, showing prominent abnormal facial structures and ocular defects. In vitro assays suggest that this mutation causes a "gain of function" in the transcriptional activation of AP-2alpha. These mice enable us to address more specifically the developmental role of Tcfap2a in the eye and middle ear and are the first report of a mutation in a gene specifically causing middle ear abnormalities, leading to conductive hearing loss.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181535     DOI: 10.1007/s00335-004-2334-z

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  33 in total

1.  The sharpening of cochlear frequency selectivity in the normal and abnormal cochlea.

Authors:  E F Evans
Journal:  Audiology       Date:  1975

2.  AP-2alpha transcription factor is required for early morphogenesis of the lens vesicle.

Authors:  J A West-Mays; J Zhang; T Nottoli; S Hagopian-Donaldson; D Libby; K J Strissel; T Williams
Journal:  Dev Biol       Date:  1999-02-01       Impact factor: 3.582

3.  Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation.

Authors:  I Satokata; L Ma; H Ohshima; M Bei; I Woo; K Nishizawa; T Maeda; Y Takano; M Uchiyama; S Heaney; H Peters; Z Tang; R Maxson; R Maas
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

4.  A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma.

Authors:  J M Bosher; N F Totty; J J Hsuan; T Williams; H C Hurst
Journal:  Oncogene       Date:  1996-10-17       Impact factor: 9.867

Review 5.  Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control.

Authors:  K Hilger-Eversheim; M Moser; H Schorle; R Buettner
Journal:  Gene       Date:  2000-12-30       Impact factor: 3.688

6.  Identification of novel human WW domain-containing proteins by cloning of ligand targets.

Authors:  G Pirozzi; S J McConnell; A J Uveges; J M Carter; A B Sparks; B K Kay; D M Fowlkes
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

7.  Characterization of the activation domains of AP-2 family transcription factors.

Authors:  S Wankhade; Y Yu; J Weinberg; M A Tainsky; P Kannan
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

Review 8.  Distal 6p deletion syndrome: a report of a case with anterior chamber eye anomaly and review of published reports.

Authors:  C J Law; A M Fisher; I K Temple
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

9.  The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules.

Authors:  H I Chen; M Sudol
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

10.  Transcription factor AP-2 essential for cranial closure and craniofacial development.

Authors:  H Schorle; P Meier; M Buchert; R Jaenisch; P J Mitchell
Journal:  Nature       Date:  1996-05-16       Impact factor: 49.962

View more
  11 in total

1.  Identification and analysis of a conserved Tcfap2a intronic enhancer element required for expression in facial and limb bud mesenchyme.

Authors:  Weiguo Feng; Jian Huang; Jian Zhang; Trevor Williams
Journal:  Mol Cell Biol       Date:  2007-11-05       Impact factor: 4.272

2.  [Characterization of ENU-mutant mice. Animal models for human diseases using morphological and molecular methods].

Authors:  S Wagner; J Calzada-Wack; M Rosemann; L Becker; M Tost; P Silva-Buttkus; T Klein-Rodewald; H Fuchs; F Neff; M Hrabé de Angelis; I Esposito
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 3.  Ocular manifestations of branchio-oculo-facial syndrome: report of a novel mutation and review of the literature.

Authors:  M S Al-Dosari; M Almazyad; L Al-Ebdi; J Y Mohamed; Saad Al-Dahmash; Hassan Al-Dhibi; Eman Al-Kahtani; Shahira Al-Turkmani; Hisham Alkuraya; B D Hall; F S Alkuraya
Journal:  Mol Vis       Date:  2010-05-08       Impact factor: 2.367

4.  Genome-wide mapping of global-to-local genetic effects on human facial shape.

Authors:  Peter Claes; Jasmien Roosenboom; Julie D White; Tomek Swigut; Dzemila Sero; Jiarui Li; Myoung Keun Lee; Arslan Zaidi; Brooke C Mattern; Corey Liebowitz; Laurel Pearson; Tomás González; Elizabeth J Leslie; Jenna C Carlson; Ekaterina Orlova; Paul Suetens; Dirk Vandermeulen; Eleanor Feingold; Mary L Marazita; John R Shaffer; Joanna Wysocka; Mark D Shriver; Seth M Weinberg
Journal:  Nat Genet       Date:  2018-02-19       Impact factor: 38.330

5.  TFAP2A mutations result in branchio-oculo-facial syndrome.

Authors:  Jeff M Milunsky; Tom A Maher; Geping Zhao; Amy E Roberts; Heather J Stalker; Roberto T Zori; Michelle N Burch; Michele Clemens; John B Mulliken; Rosemarie Smith; Angela E Lin
Journal:  Am J Hum Genet       Date:  2008-05       Impact factor: 11.025

6.  A new mouse mutant for the LDL receptor identified using ENU mutagenesis.

Authors:  Karen L Svenson; Nadav Ahituv; Rebecca S Durgin; Holly Savage; Phyllis A Magnani; Oded Foreman; Beverly Paigen; Luanne L Peters
Journal:  J Lipid Res       Date:  2008-07-15       Impact factor: 5.922

7.  Neurobehavioral mutants identified in an ENU-mutagenesis project.

Authors:  Melloni N Cook; Jonathan P Dunning; Ronald G Wiley; Elissa J Chesler; Dabney K Johnson; Darla R Miller; Dan Goldowitz
Journal:  Mamm Genome       Date:  2007-07-15       Impact factor: 2.957

8.  Analysis of TFAP2A mutations in Branchio-Oculo-Facial Syndrome indicates functional complexity within the AP-2α DNA-binding domain.

Authors:  Hong Li; Ryan Sheridan; Trevor Williams
Journal:  Hum Mol Genet       Date:  2013-04-10       Impact factor: 6.150

9.  Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators.

Authors:  Gaia Gestri; Robert J Osborne; Alexander W Wyatt; Dianne Gerrelli; Susan Gribble; Helen Stewart; Alan Fryer; David J Bunyan; Katrina Prescott; J Richard O Collin; Tomas Fitzgerald; David Robinson; Nigel P Carter; Stephen W Wilson; Nicola K Ragge
Journal:  Hum Genet       Date:  2009-12       Impact factor: 4.132

10.  Association of TFAP2A gene polymorphism with susceptibility to non-syndromic cleft lip with or without palate risk in south Indian population.

Authors:  Venkatesh Babu Gurramkonda; Altaf Hussain Syed; Jyotsna Murthy; Bhaskar V K S Lakkakula
Journal:  Meta Gene       Date:  2016-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.